Literature DB >> 7268825

Renal excretion of sulphamethoxazole and its metabolite N4-acetylsulphamethoxazole in patients with impaired kidney function.

T B Vree, Y A Hekster, J E Damsma, R van Dalen, J C Hafkenscheid, W T Friesen.   

Abstract

Plasma and urine concentrations of creatinine, sulphamethoxazole and its metabolite N4-acetylsulphamethoxazole were measured in patients with varying degrees of kidney impairment. The plasma elimination half-life of sulphamethoxazole is not influenced by the kidney function, while the half-life of the metabolite is fully dependent on the kidney function. The renal clearances of the metabolites and that of the parent compound under alkaline urine conditions are linearly related to the creatinine clearance. Kidney impairment affects only the renal clearance of the metabolite, whereas sulphamethoxazole is metabolized (acetylated) independently of kidney function.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7268825     DOI: 10.1097/00007691-198102000-00003

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  2 in total

1.  Dosage adjustment in renal insufficiency.

Authors:  G E Mawer
Journal:  Br J Clin Pharmacol       Date:  1982-02       Impact factor: 4.335

2.  Pharmacokinetics and mechanism of renal excretion of short acting sulphonamides and N4-acetylsulphonamide derivatives in man. Structural requirements of sulphonamides for active tubular secretion.

Authors:  T B Vree; Y A Hekster; J E Damsma; M Tijhuis; W T Friesen
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.